Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SSL Expert Dr. Bernhard Stapp Joins Board of Aledia

Published: Monday, May 27, 2013
Last Updated: Monday, May 27, 2013
Bookmark and Share
Former OSRAM general manager and CTO has played key role in industry’s evolution, will aid Aledia’s move towards industrialization.

Aledia has announced that solid-state lighting (SSL) industry veteran Dr. Bernhard Stapp has joined its board of directors.

Stapp brings more than a dozen years of executive experience in LED lighting technologies to Aledia, most recently in senior management positions at OSRAM, a global leader in SSL manufacturing and marketing.

As general manager and senior vice president of OSRAM AG’s SSL unit, Stapp was responsible for the company’s professional LED and OLED business.

Earlier, as SSL vice president and general manager at OSRAM Opto Semiconductors, he launched and managed the general-lighting LED business and oversaw launch of the world’s first OLED lighting products.

Prior to that, Stapp was vice president and CTO of the semiconductor company, where he oversaw global LED, laser and OLED R&D.

Earlier in his career, he held a variety of management positions in Siemens AG’s Corporate Technology division.

“Aledia’s mission is to bring fundamental change to the world’s lighting markets by making LED technology substantially more affordable and more versatile, with better performance and fewer limitations,” said Giorgio Anania, Aledia’s co-founder, president and CEO.

Anania continued, “Bernhard has been a key player at the heart of the global LED industry since its inception, and also has an outstanding technical background. His unique perspective on this industry’s future will be invaluable as Aledia moves into the next stage of its evolution.”

WireLED®, Aledia’s unique 3D microwire GaN-on-silicon technology, was developed at the CEA-Leti nanotech research institute in Grenoble.

It addresses the basic technical and economic challenges facing LED lighting by allowing production of LEDs on inexpensive industry-standard 200mm silicon wafers using standard semiconductor processes and tools.

“Aledia’s technology is, quite simply, a breakthrough for the entire LED sector,” said Stapp. “It can meet the industry’s critical requirement for cost-reduction, while using far simpler production processes and much less material than conventional approaches. I am very excited about the opportunity to join this team.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Vaccination Against UTIs
Researchers have successfully vaccinated mice against E.coli growth in the bladder and kidneys.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Fighting Off HIV Infection Closer to Reality
Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.
Powerful New Tools to Combat Zika
Researchers have created a way to replicate the stucture of Zika virus, removing the genes that make the virus infectious.
More Immunotherapy Options Approved for Lung Cancer
The FDA has approved a new immunotherapy drug for certain patients with non-small cell lung cancer.
Dissecting Bacterial Infections at the Single-Cell Level
Researchers have used single-cell analysis technology to provide new insight into the Salmonella infection process.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
DNA-Based Zika Vaccine Showed Protection From Infection, Brain Damage and Death
The study is the first of its kind to analyze a vaccine in an animal model that is susceptible to the disease, providing information regarding the protective impact of the immune response in susceptible individuals.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!